1-3 of 3
David L. Murray
Close
Sort by
Journal Articles

Prevalence of heavy chain MGUS by race and family history risk groups using a high-sensitivity screening method

Clinical Trials & Observations
Celine M. Vachon, Josiah Murray, Cristine Allmer, Dirk Larson, Aaron D. Norman, Jason P. Sinnwell, Angela Dispenzieri, Geffen Kleinstern, Alissa Visram, Robert A. Kyle, S. Vincent Rajkumar, Susan L. Slager, Shaji K. Kumar, David L. Murray
Journal: Blood Advances
Blood Adv (2022) 6 (12): 3746–3750.
https://doi.org/10.1182/bloodadvances.2021006201
Published: 2022
Includes: Supplemental data
Journal Articles

IGVL gene region usage correlates with distinct clinical presentation in IgM vs non-IgM light chain amyloidosis

Clinical Trials & Observations
Surbhi Sidana, Surendra Dasari, Taxiarchis V. Kourelis, Angela Dispenzieri, David L. Murray, Rebecca L. King, Ellen D. McPhail, Marina Ramirez-Alvarado, Shaji K. Kumar, Morie A. Gertz
Journal: Blood Advances
Blood Adv (2021) 5 (8): 2101–2105.
https://doi.org/10.1182/bloodadvances.2020003671
Published: 2021
Includes: Supplemental data
Journal Articles

Utility of serum free light chain ratio in response definition in patients with multiple myeloma

Clinical Trials & Observations
Nadine Abdallah, Prashant Kapoor, David L. Murray, Francis K. Buadi, David Dingli, Angela Dispenzieri, Morie A. Gertz, Ronald S. Go, Wilson I. Gonsalves, Suzanne R. Hayman, Taxiarchis V. Kourelis, Martha Q. Lacy, Nelson Leung, John A. Lust, Eli Muchtar, Rahma Warsame, Robert A. Kyle, S. Vincent Rajkumar, Shaji K. Kumar
Journal: Blood Advances
Blood Adv (2020) 4 (2): 322–326.
https://doi.org/10.1182/bloodadvances.2019001099
Published: 2020